Secondary healing strategy for difficult wound closure in invasive vulvar cancer: a pilot case-control study

Altamiro Ribeiro Dias-Jr, José Maria Soares-Jr, Maria Beatriz Sartor de Faria, Maria Luiza Noqueira Dias Genta, Jesus Paula Carvalho, Edmund C Baracat, Altamiro Ribeiro Dias-Jr, José Maria Soares-Jr, Maria Beatriz Sartor de Faria, Maria Luiza Noqueira Dias Genta, Jesus Paula Carvalho, Edmund C Baracat

Abstract

Objectives: Despite the number of surgical advances and innovations in techniques over time, radical vulvectomy frequently results in substantial loss of tissue that cannot be primarily closed without tension, the mobilization of surrounding tissues or even the rotation of myocutaneous flaps. The aim of this study was to evaluate the feasibility of leaving the surgical vulvar open wound for secondary healing in situations where primary closure of the vulvar wound is not possible.

Methods: This case-control pilot study analyzed 16 women with a diagnosis of squamous cell carcinoma of the vulva who first underwent inguinofemoral lymphadenectomy, 6-week sessions of chemotherapy and 25 daily sessions of radiotherapy. Afterward, excision of the vulvar lesion with free margins was performed between January 2011 and July 2017. Twelve patients underwent primary closure of the wound (control), and in 4 patients, the surgical wound was left open for secondary healing by means of a hydrofiber (case). The inclusion criteria were a) FIGO-2009 stage II up to IIIC; b) squamous cell carcinoma; and c) no evidence of pelvic or extrapelvic disease or pelvic nodal involvement. The exclusion criteria were extrapelvic disease or pelvic nodal involvement, another primary cancer, or a poor clinical condition. ClinicalTrials.gov: NCT02067052.

Results: The mean age of the patients at the time of the intervention was 62.1. The distribution of the stages was as follows: II, n=6 (37 %); IIIA, n=1 (6%), IIIB, n=1 (6%) and IIIC, n=8 (51%). The mean operative time was 45 minutes. The hospital stay duration was 2 days. Full vulvar healing occurred after an average of 30 days in the control group and after an average of 50 days in the case group.

Conclusion: A secondary healing strategy may be an option for the treatment of vulvar cancer in situations of non-extensive surgical wounds when primary closure of the wound is not possible.

Conflict of interest statement

No potential conflict of interest was reported.

Figures

Figure 1
Figure 1
Photograph of the vulvar region of a patient with the secondary healing strategy: A. Vulvar size defect after resection (immediately after surgery); B. Curative approach with the hydrofiber; C. Follow-up 2 weeks after surgery; D. follow-up 7 weeks after surgery.

References

    1. Woelber L, Trillsch F, Kock L, Grimm D, Petersen C, Choschzick M, et al. Management of patients with vulvar cancer: a perspective review according to tumour stage. Ther Adv Med Oncol. 2013;5((3)):183–92. doi: 10.1177/1758834012471699.
    1. Wills A, Obermair A. A review of complications associated with the surgical treatment of vulvar cancer. Gynecol Oncol. 2013;131((2)):467–79. doi: 10.1016/j.ygyno.2013.07.082.
    1. Magrina JF, Gonzalez-Bosquet J, Weaver AL, Gaffey TA, Webb MJ, Podratz KC, et al. Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery. Gynecol Oncol. 1998;71((1)):116–21. doi: 10.1006/gyno.1998.5149.
    1. Walker KF, Day H, Abu J, Nunns D, Williamson K, Duncan T. Do surgical techniques used in groin lymphadenectomy for vulval cancer affect morbidity rates? Int J Gynecol Cancer. 2011;21((8)):1495–9. doi: 10.1097/IGC.0b013e318228f314.
    1. De Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002;95((11)):2331–8. doi: 10.1002/cncr.10969.
    1. Caruso DM, Foster KN, Hermans MH, Rick C. Aquacel Ag in the management of partial-thickness burns: results of a clinical trial. J Burn Care Rehabil. 2004;25((1)):89–97. doi: 10.1097/01.BCR.0000107202.85453.63.
    1. Arvas M, Kahramanoglu I, Bese T, Turan H, Sozen I, Ilvan S, et al. The Role of Pathological Margin Distance and Prognostic Factors After Primary Surgery in Squamous Cell Carcinoma of the Vulva. Int J Gynecol Cancer. 2018;28((3)):623–31. doi: 10.1097/IGC.0000000000001195.
    1. Leminen A, Forss M, Paavonen J. Wound complications in patients with carcinoma of the vulva. Comparison between radical and modified vulvectomies. Eur J Obstet Gynecol Reprod Biol. 2000;93((2)):193–7. doi: 10.1016/S0301-2115(00)00273-6.
    1. Hinten F, van den Einden LC, Hendriks JC, van der Zee AG, Bulten J, Massuger L, et al. Risk factors for short- and long-term complications after groin surgery in vulvar cancer. Br J Cancer. 2011;105((9)):1279–87. doi: 10.1038/bjc.2011.407.
    1. Schimp VL, Worley C, Brunello S, Levenback CC, Wolf JK, Sun CC, et al. Vacuum-assisted closure in the treatment of gynecologic oncology wound failures. Gynecol Oncol. 2004;92((2)):586–91. doi: 10.1016/j.ygyno.2003.10.055.
    1. Thackham JA, McElwain DL, Long RJ. The use of hyperbaric oxygen therapy to treat chronic wounds: A review. Wound Repair Regen. 2008;16((3)):321–30. doi: 10.1111/j.1524-475X.2008.00372.x.

Source: PubMed

3
Suscribir